Tyrolpath adopts Techcyte Fusion AP for dermatopathology sign-out
Tyrolpath, one of Austria’s largest private pathology labs, has started clinical sign-out in Techcyte Fusion AP, beginning with dermatopathology. The rollout extends a digital pathology workflow that already includes Techcyte SureView for cervical cytology and could expand across more of the lab’s anatomic pathology work this fall.
Why it matters: - Tyrolpath is moving more pathology work into a single digital platform, which can streamline review, consultation, and reporting across different workflows. - The rollout links cervical cytology and histology on Techcyte’s enterprise platform, giving the laboratory a path toward broader digital pathology adoption. - Techcyte said the expansion also positions Tyrolpath to extend digital review and AI support into additional laboratory areas, including microbiology.
What happened: - Techcyte announced that Tyrolpath is now using Techcyte Fusion AP for clinical sign-out, starting with dermatopathology. - Tyrolpath began clinical sign-out of dermatopathology cases in Fusion AP in September. - The laboratory is also running a validation study this fall to expand Fusion AP across more of its anatomic pathology workload. - Tyrolpath previously implemented Techcyte SureView for cervical cytology in 2025.
The details: - Tyrolpath added five Evident Pramana HT-4 Cubiq scanners this year to digitize histology slides. - Fusion AP gives pathologists a single browser-based worklist where whole-slide images, case information, and reports appear together. - Pathologists can review cases together in real time or send cases for internal consultation from the same workspace. - Stains and recuts can be ordered from within each case. - Reports can be built from synoptic templates or institution-specific templates. - AI algorithms from Techcyte and third-party developers run in the same workspace and flag areas of interest for review. - Fusion AP is CE-marked in the EU.
Between the lines: - Tyrolpath’s deployment shows how pathology labs are combining cytology, histology, and AI tools inside one enterprise system instead of using separate workflows. - The move also suggests Techcyte is pushing Fusion beyond a single-use application toward a broader digital pathology platform for multiple lab services. - Dr. Peter Obrist said Tyrolpath’s goal has been to make digital pathology part of everyday work across the laboratory, and that one platform gives the lab a foundation to keep building on.
What's next: - Tyrolpath will continue validating Fusion AP for broader anatomic pathology use this fall. - Techcyte expects to support Tyrolpath as it brings digital review and AI into additional areas of the laboratory. - The company said microbiology is one of the next possible workflow areas for the lab.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
World Post Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.